Biotron Labortories Private Limited
Produces diagnostic tubes and reagents for independent diagnostic/pathological laboratories.
2001 | Thane, Maharashtra (India) | Active
Biotron Labortories Profile
Key Indicators
- Authorised Capital ₹ 1.00 M
- Paid Up Capital ₹ 0.30 M
- Company Age 24 Year, 25 Days
- Last Filing with ROC 31 Mar 2024
- Revenue Growth %
- Profit Growth -720.53%
- Ebitda -115.93%
- Net Worth -19.82%
- Total Assets -22.50%
About Biotron Labortories
Biotron Labortories Private Limited (BLPL) is a Private Limited Indian Non-Government Company incorporated in India on 02 February 2001 and has a history of 24 years. Its registered office is in Thane, Maharashtra, India.
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 1.00 M and a paid-up capital of Rs 0.30 M, as per Ministry of Corporate Affairs (MCA) records.
Hitendra Shah, Suresh Ghatalia, and Idiculla Idiculla serve as directors at the Company.
Company Details
- Location
Thane, Maharashtra, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
-
- Social Media -
Corporate Identity Details
- CIN/LLPIN
U24239MH2001PTC130704
- Company No.
130704
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
02 Feb 2001
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Mumbai
Industry
Healthcare
Who are the key members and board of directors at Biotron Labortories?
Board Members (3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Suresh Ghatalia  | Director | 02-Feb-2001 | Current |
| Hitendra Shah | Director | 02-Feb-2001 | Current |
| Idiculla Idiculla | Director | 02-Feb-2001 | Current |
Financial Performance of Biotron Labortories.
Biotron Labortories Private Limited, for the financial year ended 2020, experienced no change in revenue, with a 0% increase. The company also saw a substantial fall in profitability, with a 720.53% decrease in profit. The company's net worth observed a substantial decline by a decrease of 19.82%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Biotron Labortories?
In 2019, Biotron Labortories had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
_PRIVATE_LIMITED.webp)
Biolab Diagnostics (India ) Private LimitedHitendra Shah, Suresh Ghatalia and 1 more are mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Biotron Labortories?
Unlock and access historical data on people associated with Biotron Labortories, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Biotron Labortories, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Biotron Labortories's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.